​

Disc Medicine (IRON) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChart

IRON Stock Forecast

Disc Medicine (IRON) stock forecast, based on 11 Wall Street analysts, predicts a 12-month average price target of $110.25, with a high of $153.00 and a low of $75.00. This represents a 70.19% increase from the last price of $64.78.

- $40 $80 $120 $160 $200 High: $153 Avg: $110.25 Low: $75 Last Closed Price: $64.78

IRON Stock Rating

Disc Medicine stock's rating consensus is Buy, based on 11 Wall Street analysts. The breakdown includes 1 Strong Buy (9.09%), 10 Buy (90.91%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 11 0 10 1 Strong Sell Sell Hold Buy Strong Buy

IRON Price Target Upside V Benchmarks

TypeNameUpside
StockDisc Medicine70.19%
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends

1M3M12M
# Anlaysts-611
Avg Price Target-$103.00$110.91
Last Closing Price$64.78$64.78$64.78
Upside/Downside-59.00%71.21%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Apr, 26111---12
Mar, 26111---12
Feb, 26111---12
Jan, 26112---13
Dec, 25112---13
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Feb 17, 2026Wedbush$88.00$60.2845.99%35.84%
Feb 17, 2026Kristen KluskaCantor Fitzgerald$125.00$60.24107.50%92.96%
Feb 17, 2026Morgan Stanley$75.00$60.3924.19%15.78%
Feb 17, 2026Stifel Nicolaus$110.00$61.4379.07%69.81%
Feb 17, 2026Evan SeigermanBMO Capital$100.00$61.4862.65%54.37%
Jan 08, 2026Morgan Stanley$120.00$80.9448.26%85.24%
Dec 08, 2025Martin AusterRaymond James$117.00$96.3221.47%80.61%
Nov 10, 2025Truist Financial$114.00$82.7737.73%75.98%
Oct 17, 2025National Bank$153.00$94.1962.44%136.18%
Oct 17, 2025Raymond James$108.00$74.3645.24%66.72%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Feb 17, 2026Cantor FitzgeraldOverweightOverweighthold
Feb 17, 2026BMO CapitalOutperformOutperformhold
Jan 15, 2026UBSOverweightOverweighthold
Jan 15, 2026WedbushOutperformOutperformhold
Jan 08, 2026Morgan StanleyOverweightOverweighthold
Dec 19, 2025Cowen & Co.BuyBuyhold
Dec 08, 2025Raymond JamesStrong BuyStrong Buyhold
Oct 17, 2025Cantor FitzgeraldOverweightOverweighthold
Oct 17, 2025Raymond JamesStrong BuyStrong Buyhold
Oct 17, 2025WedbushOutperformOutperformhold

Financial Forecast

EPS Forecast

$-10 $-7 $-4 $-1 $2 $5 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-3.42$-3.96$-6.01---
Avg Forecast$-3.25$-4.13$-5.21$-5.35$-4.12$-0.32
High Forecast$-2.96$-3.94$-4.20$-3.89$2.49$-0.32
Low Forecast$-3.58$-4.50$-6.08$-8.11$-8.83$-0.32
Surprise %5.23%-4.12%15.36%---

Revenue Forecast

$0 $70M $140M $210M $280M $350M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported------
Avg Forecast--$6.06M$38.61M$117.86M$308.23M
High Forecast--$6.07M$38.61M$117.86M$308.23M
Low Forecast--$6.04M$38.61M$117.86M$308.23M
Surprise %------

Net Income Forecast

$-250M $-180M $-110M $-40M $30M $100M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-76.43M$-109.36M$-212.18M---
Avg Forecast$-76.43M$-94.10M$-114.74M$-178.09M$-145.87M$-7.04M
High Forecast$-66.05M$-87.87M$-93.71M$-86.87M$55.55M$-7.04M
Low Forecast$-79.93M$-100.32M$-135.76M$-181.01M$-197.16M$-7.04M
Surprise %-16.22%84.93%---

IRON Forecast FAQ

Is Disc Medicine stock a buy?

Disc Medicine stock has a consensus rating of Buy, based on 11 Wall Street analysts. The rating breakdown includes 1 Strong Buy, 10 Buy, 0 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Disc Medicine is a favorable investment for most analysts.

What is Disc Medicine's price target?

Disc Medicine's price target, set by 11 Wall Street analysts, averages $110.25 over the next 12 months. The price target range spans from $75 at the low end to $153 at the high end, suggesting a potential 70.19% change from the previous closing price of $64.78.

How does Disc Medicine stock forecast compare to its benchmarks?

Disc Medicine's stock forecast shows a 70.19% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for Disc Medicine over the past three months?

  • April 2026: 8.33% Strong Buy, 91.67% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • March 2026: 8.33% Strong Buy, 91.67% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • February 2026: 8.33% Strong Buy, 91.67% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is Disc Medicine’s EPS forecast?

Disc Medicine's average annual EPS forecast for its fiscal year ending in December 2026 is $-5.35, marking a -10.98% decrease from the reported $-6.01 in 2025. Estimates for the following years are $-4.12 in 2027, and $-0.32 in 2028.

What is Disc Medicine’s revenue forecast?

Disc Medicine's average annual revenue forecast for its fiscal year ending in December 2026 is $38.61M, reflecting a 0% decrease from the reported $0 in 2025. The forecast for 2027 is $117.86M, and $308.23M for 2028.

What is Disc Medicine’s net income forecast?

Disc Medicine's net income forecast for the fiscal year ending in December 2026 stands at $-178M, representing a -16.07% decrease from the reported $-212M in 2025. Projections indicate $-146M in 2027, and $-7.041M in 2028.